Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label ExtensionRenato Mantegazza, Maria da Penha Ananias Morita, Srikanth Muppidi et al.|Neurology|2020Cited by 80